Intracameral bevacizumab effectively reduces aqueous vascular endothelial growth factor concentrations in neovascular glaucoma
- PMID: 18617542
- DOI: 10.1136/bjo.2008.145714
Intracameral bevacizumab effectively reduces aqueous vascular endothelial growth factor concentrations in neovascular glaucoma
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources